Smart Connected metered-dose inhaler

Sales markets: Western Europe | Eastern Europe | Middle East | Asia | Australia | North America | Central/South America

Product description

H&T Presspart and Cohero Health have developed the first market-ready, fully embedded and connected metered-dose inhaler (MDI).By tracking and recording data on the use of medications, and sharing it with patients and physicians via a mobile or web app, the eMDI enables pharmaceutical manufacturers to bring the best possible care to those with asthma and COPD.

The eMDI improves patients’ adherence to medication doses, encourages self-care, and helps health professionals maintain real-time monitoring. The device integrates with Cohero Health’s BreatheSmart, the only respiratory disease management platform that enables tracking of both controller and rescue medications, and measures lung function with clinical accuracy. It then transfers the data wirelessly to a smart phone app, or directly into a patient’s medical records.

This data capture, along with analytical and predictive capabilities, supports real-time alerts and informs clinical decision-making. Also, as an evolution of existing inhaler technology, the eMDI is quick and cost-effective to adopt, and easy for patients to use.

Read more


Origin United Kingdom
Selling Points Product Performance; Quality Service
Show more specifications

More products from H&T Presspart

View all our products (9)

Products from other suppliers

Smart Connected metered-dose inhaler

Contact information




View all contact information